Unknown

Dataset Information

0

Boomerang: A method for recursive reclassification.


ABSTRACT: While there are many validated prognostic classifiers used in practice, often their accuracy is modest and heterogeneity in clinical outcomes exists in one or more risk subgroups. Newly available markers, such as genomic mutations, may be used to improve the accuracy of an existing classifier by reclassifying patients from a heterogenous group into a higher or lower risk category. The statistical tools typically applied to develop the initial classifiers are not easily adapted toward this reclassification goal. In this article, we develop a new method designed to refine an existing prognostic classifier by incorporating new markers. The two-stage algorithm called Boomerang first searches for modifications of the existing classifier that increase the overall predictive accuracy and then merges to a prespecified number of risk groups. Resampling techniques are proposed to assess the improvement in predictive accuracy when an independent validation data set is not available. The performance of the algorithm is assessed under various simulation scenarios where the marker frequency, degree of censoring, and total sample size are varied. The results suggest that the method selects few false positive markers and is able to improve the predictive accuracy of the classifier in many settings. Lastly, the method is illustrated on an acute myeloid leukemia data set where a new refined classifier incorporates four new mutations into the existing three category classifier and is validated on an independent data set.

SUBMITTER: Devlin SM 

PROVIDER: S-EPMC4940305 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Boomerang: A method for recursive reclassification.

Devlin Sean M SM   Ostrovnaya Irina I   Gönen Mithat M  

Biometrics 20160111 3


While there are many validated prognostic classifiers used in practice, often their accuracy is modest and heterogeneity in clinical outcomes exists in one or more risk subgroups. Newly available markers, such as genomic mutations, may be used to improve the accuracy of an existing classifier by reclassifying patients from a heterogenous group into a higher or lower risk category. The statistical tools typically applied to develop the initial classifiers are not easily adapted toward this reclas  ...[more]

Similar Datasets

| S-EPMC4385608 | biostudies-literature
| S-EPMC4032201 | biostudies-other
| S-EPMC2909310 | biostudies-other
| S-EPMC1736093 | biostudies-other
| S-EPMC10506123 | biostudies-literature
| S-EPMC5181554 | biostudies-literature
| S-EPMC7512538 | biostudies-literature
| S-EPMC2755923 | biostudies-literature
| S-EPMC2988352 | biostudies-literature
| S-EPMC9629703 | biostudies-literature